Extracellular vesicles mediate intercellular transfer of PD-L1 and bystander T-cell suppression
Open Access
- 17 April 2026
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 83 (1)
Abstract
Extracellular vesicles (EVs) carrying programmed death-ligand 1(PD-L1) on their membranes regulate immune responses. While membrane PD-L1 can be exchanged between tumor and immune cells through immune synapse, it remains unclear whether PD-L1 exchange occurs in non-immune cells. Here, we investigated the transfer of PD-L1 onto the surface of various recipient cells via EVs. Genetically engineered 293T PD-L1+ cells, when co-cultured with PD-L1neg isogenic or heterologous cells, showed a ~ 6 to 22-fold increase in surface PD-L1 on 100% of PD-L1neg bystander recipient cells. Purified PD-L1+ EVs retained competency to transfer PD-L1 to recipient PD-L1neg cell surfaces (> six fold increase). Importantly, transferred PD-L1 mediates binding to PD-1 and facilitates suppression of proliferation of activated T cells. Metabolically inert PD-L1neg 293T cells also acquired PD-L1 on their surfaces from PD-L1+ cells, or PD-L1+EVs, indicating a passive transfer mechanism independent of active cellular uptake. Overall, these findings reveal a distinct, passive and functional mechanism of PD-L1 transfer via EVs, defining previously underappreciated cell-physiological pathway that enables immune suppression and evasion by PD-L1neg somatic cells.Keywords
Funding Information
- Dr. Ralph and Marian Falk Medical Research Trust
- Harrington Discovery Institute, University Hospitals
This publication has 37 references indexed in Scilit:
- Trogocytosis-mediated immune evasion in the tumor microenvironmentExperimental & Molecular Medicine, 2025
- PD-L1/L2 protein levels rapidly increase on monocytes via trogocytosis from tumor cells in classical Hodgkin lymphomaLeukemia, 2020
- A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape ProjectLung Cancer, 2019
- Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and MemoryCell, 2019
- Clinical landscape of cancer metastasesCancer Medicine, 2018
- Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non–small cell lung cancerLung Cancer, 2016
- Biogenesis and secretion of exosomesCurrent Opinion in Cell Biology, 2014
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkersNature Cell Biology, 2008
- What is trogocytosis and what is its purpose?Nature Immunology, 2003
- Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasionNature Medicine, 2002